IL129627A0 - Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes - Google Patents
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesInfo
- Publication number
- IL129627A0 IL129627A0 IL12962797A IL12962797A IL129627A0 IL 129627 A0 IL129627 A0 IL 129627A0 IL 12962797 A IL12962797 A IL 12962797A IL 12962797 A IL12962797 A IL 12962797A IL 129627 A0 IL129627 A0 IL 129627A0
- Authority
- IL
- Israel
- Prior art keywords
- syndromes
- prevention
- treatment
- related diseases
- derivatives useful
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940011871 estrogen Drugs 0.000 title abstract 2
- 239000000262 estrogen Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK119596 | 1996-10-28 | ||
| PCT/DK1997/000486 WO1998018779A1 (en) | 1996-10-28 | 1997-10-28 | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129627A0 true IL129627A0 (en) | 2000-02-29 |
Family
ID=8102047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12962797A IL129627A0 (en) | 1996-10-28 | 1997-10-28 | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0937062B1 (no) |
| JP (1) | JP2001502711A (no) |
| AT (1) | ATE229519T1 (no) |
| AU (1) | AU4772397A (no) |
| CA (1) | CA2269973A1 (no) |
| DE (1) | DE69717844T2 (no) |
| DK (1) | DK0937062T3 (no) |
| ES (1) | ES2188909T3 (no) |
| IL (1) | IL129627A0 (no) |
| NO (1) | NO992006L (no) |
| WO (1) | WO1998018779A1 (no) |
| ZA (1) | ZA979650B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356986A1 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| JP4976649B2 (ja) * | 2004-09-21 | 2012-07-18 | マーシャル エドワーズ，インク． | 化合物 |
| EP1794141B1 (en) | 2004-09-21 | 2011-11-09 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
| US9708283B2 (en) | 2010-11-01 | 2017-07-18 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
| CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
| EP3681495A4 (en) * | 2017-09-15 | 2021-06-02 | Nyrada Pty Limited | TREATMENT OF EXCITOTOXICITY |
| CN115003295B (zh) * | 2019-12-12 | 2025-05-06 | 冰洲石生物科技公司 | 具有雌激素受体降解活性的新型色满衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
| DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-28 WO PCT/DK1997/000486 patent/WO1998018779A1/en not_active Ceased
- 1997-10-28 CA CA002269973A patent/CA2269973A1/en not_active Abandoned
- 1997-10-28 JP JP10519945A patent/JP2001502711A/ja active Pending
- 1997-10-28 ZA ZA9709650A patent/ZA979650B/xx unknown
- 1997-10-28 DE DE69717844T patent/DE69717844T2/de not_active Expired - Fee Related
- 1997-10-28 ES ES97910267T patent/ES2188909T3/es not_active Expired - Lifetime
- 1997-10-28 AU AU47723/97A patent/AU4772397A/en not_active Abandoned
- 1997-10-28 EP EP97910267A patent/EP0937062B1/en not_active Expired - Lifetime
- 1997-10-28 IL IL12962797A patent/IL129627A0/xx unknown
- 1997-10-28 DK DK97910267T patent/DK0937062T3/da active
- 1997-10-28 AT AT97910267T patent/ATE229519T1/de not_active IP Right Cessation
-
1999
- 1999-04-27 NO NO992006A patent/NO992006L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO992006L (no) | 1999-06-25 |
| EP0937062A1 (en) | 1999-08-25 |
| AU4772397A (en) | 1998-05-22 |
| EP0937062B1 (en) | 2002-12-11 |
| ATE229519T1 (de) | 2002-12-15 |
| JP2001502711A (ja) | 2001-02-27 |
| ZA979650B (en) | 1998-04-28 |
| DK0937062T3 (da) | 2003-04-07 |
| DE69717844T2 (de) | 2003-10-02 |
| WO1998018779A1 (en) | 1998-05-07 |
| CA2269973A1 (en) | 1998-05-07 |
| ES2188909T3 (es) | 2003-07-01 |
| NO992006D0 (no) | 1999-04-27 |
| DE69717844D1 (de) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| HUT70526A (en) | Indole-2-carboxylic acid derivatives, process for producing thereof and pharmaceutical compositions comprising same compounds | |
| AU5669398A (en) | Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them | |
| AU2053597A (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| MY133647A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
| UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
| UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
| IL117091A0 (en) | Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
| EP0807633A3 (en) | Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones | |
| IL129616A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| HUP9901616A3 (en) | Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| UA35607C2 (uk) | Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання | |
| AU1306795A (en) | Anticonvulsant pseudofructopyranose sulfamates | |
| CA2282279A1 (en) | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions | |
| IL129627A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| IL129625A0 (en) | Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| AU5493298A (en) | Stabilized pharmaceutical compositions and process for the preparation thereof | |
| CA2263846A1 (en) | Novel pyranoside derivatives | |
| NO992010L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| GR1002576B (el) | Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους. | |
| MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
| NO992005L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| NO992008L (no) | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
| EP0386920A3 (en) | 2-hydroxy-3-thienyloxypropylamino derivatives |